{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:36:39Z","timestamp":1759412199972,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.vaccine.2019.08.085","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T17:17:51Z","timestamp":1567790271000},"page":"6463-6469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Measles and rubella immunity in the population of Bhutan, 2017"],"prefix":"10.1016","volume":"37","author":[{"given":"Sonam","family":"Wangchuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Nogareda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namgay","family":"Tshering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lekey","family":"Khandu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonam","family":"Pelden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Wannemuehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonam","family":"Wangdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugyen","family":"Wangchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mick","family":"Mulders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tshewang","family":"Tamang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minal K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.08.085_b0005","unstructured":"Global vaccine action plan 2011-2020. Geneva, Switzerland: World Health Organization; 2013. https:\/\/www.who.int\/immunization\/global_vaccine_action_plan\/GVAP_doc_2011_2020\/en\/. Accessed: October 30, 2018."},{"key":"10.1016\/j.vaccine.2019.08.085_b0010","first-page":"544","article-title":"Guidance for evaluating progress towards elimination of measles and rubella","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.08.085_b0015","unstructured":"World health organization regional office for South-East Asia. Bhutan, Maldives eliminate measles. New Delhi; 2017. http:\/\/www.searo.who.int\/mediacentre\/releases\/2017\/1651\/en\/. Accessed: October 30, 2018."},{"key":"10.1016\/j.vaccine.2019.08.085_b0020","unstructured":"World health organization regional office of South-East Asia. DPR Korea, Timor-Leste eliminate measles, six countries in WHO South-East Asia achieve rubella control. New Delhi; 2018. http:\/\/www.searo.who.int\/mediacentre\/releases\/2018\/1693\/en\/. Accessed: October 30, 2018."},{"key":"10.1016\/j.vaccine.2019.08.085_b0025","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/tmi.12737","article-title":"Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries","volume":"21","author":"Cutts","year":"2016","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2019.08.085_b0030","unstructured":"Measles vaccines: WHO position paper - April 2017. Wkly Epidemiol Rec 2017;92:205\u201327."},{"key":"10.1016\/j.vaccine.2019.08.085_b0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/15321819.2014.920713","article-title":"Measles vaccine potency and sero-conversion rates among infants receiving measles immunization in Ilorin, Kwara State, Nigeria","volume":"36","author":"Fowotade","year":"2015","journal-title":"J Immunoassay Immunochem"},{"key":"10.1016\/j.vaccine.2019.08.085_b0040","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1016\/j.vaccine.2018.04.036","article-title":"Assessing population immunity for measles elimination - The promise and peril of serosurveys","volume":"36","author":"Durrheim","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.085_b0045","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJMe1610620","article-title":"Measles elimination - using outbreaks to identify and close immunity gaps","volume":"375","author":"Durrheim","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.08.085_b0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jviromet.2005.08.001","article-title":"Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay","volume":"131","author":"Cohen","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2019.08.085_b0055","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1016\/j.vaccine.2014.10.061","article-title":"Measles - The epidemiology of elimination","volume":"32","author":"Durrheim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.085_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194931","article-title":"Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine","volume":"13","author":"Hachiya","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.08.085_b0065","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1016\/S2214-109X(18)30492-3","article-title":"Classification of global measles cases in 2013\u201317 as due to policy or vaccination failure: a retrospective review of global surveillance data","volume":"7","author":"Patel","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2019.08.085_b0070","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.15585\/mmwr.mm6438a7","article-title":"Measles outbreak associated with vaccine failure in adults-federated states of Micronesia, February-August 2014","volume":"64","author":"Breakwell","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2019.08.085_b0075","doi-asserted-by":"crossref","unstructured":"Hales CM, Johnson E, Helgenberger L, Papania MJ, Larzelere M, Gopalani SV, et al. Measles outbreak associated with low vaccine effectiveness among adults in Pohnpei State, Federated States of Micronesia, 2014. Open Forum Infect Dis. 2016; 3: ofw064.","DOI":"10.1093\/ofid\/ofw064"},{"key":"10.1016\/j.vaccine.2019.08.085_b0080","first-page":"23","article-title":"challenges in the post-elimination era","volume":"2018","author":"Sa Machado","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2019.08.085_b0085","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1016\/j.vaccine.2017.06.058","article-title":"An increasing, potentially measles-susceptible population over time after vaccination in Korea","volume":"35","author":"Kang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.085_b0090","unstructured":"Seventh meeting of the vaccine-preventable diseases laboratory networks in the Western Pacific Region. Manila, Philippines: World Health Organization Regional Office for the Western Pacific; 2018. https:\/\/iris.wpro.who.int\/bitstream\/handle\/10665.1\/14072\/RS-2017-GE-66-PHL-eng.pdf?ua=1. Accessed: May 6, 2019."},{"key":"10.1016\/j.vaccine.2019.08.085_b0095","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.vaccine.2012.10.089","article-title":"Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature","volume":"31","author":"Miles","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.085_b0100","unstructured":"WHO vaccine-preventable diseases: monitoring system. 2018 global summary. Retrieved April 4, 2019, from http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/countries?countrycriteria%5Bcountry%5D%5B%5D=BTN."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:36:58Z","timestamp":1759401418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19311740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":20,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0264410X19311740"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measles and rubella immunity in the population of Bhutan, 2017","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}